Journal
FRONTIERS IN IMMUNOLOGY
Volume 13, Issue -, Pages -Publisher
FRONTIERS MEDIA SA
DOI: 10.3389/fimmu.2022.1022808
Keywords
IL-7; adjuvant; cancer vaccines; T cell immune response; T cell memory
Categories
Funding
- National Natural Science Foundation of China
- Natural Science Foundation of Chongqing
- Chongqing Science and Health Joint Medical High-end Talent Project
- Science and Technology Research Program of Chongqing Municipal Education Commission
- CQMU Program for Youth Innovation in Future Medicine
- [81871653]
- [cstc2021jsyj-yzysbAX0018]
- [2022GDRC012]
- [KJZD-K202100402]
- [KJQN201900449]
- [W0073]
Ask authors/readers for more resources
Cancer vaccines have shown specificity, effectiveness, and safety as an alternative immunotherapeutic strategy. However, maintaining long-term immune memory, especially T cell memory, after vaccination is still a challenge. IL-7, as an adjuvant, has potential in the development of cancer vaccines.
Cancer vaccines exhibit specificity, effectiveness, and safety as an alternative immunotherapeutic strategy to struggle against malignant diseases, especially with the rapid development of mRNA cancer vaccines in recent years. However, how to maintain long-term immune memory after vaccination, especially T cells memory, to fulfill lasting surveillance against cancers, is still a challenging issue for researchers all over the world. IL-7 is critical for the development, maintenance, and proliferation of T lymphocytes, highlighting its potential role as an adjuvant in the development of cancer vaccines. Here, we summarized the IL-7/IL-7 receptor signaling in the development of T lymphocytes, the biological function of IL-7 in the maintenance and survival of T lymphocytes, the performance of IL-7 in pre-clinical and clinical trials of cancer vaccines, and the rationale to apply IL-7 as an adjuvant in cancer vaccine-based therapeutic strategy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available